[Trial chemoprophylaxis of traveler's diarrhea using nifuroxazide].
Traveler's diarrhea is a very common condition that affects approximately 12 million subjects each year. This disorder is benign but nevertheless interferes with the traveler's plans in 40% of cases. Several drugs have been used for prophylaxis, in association with appropriate precautions concerning food and drink. Trimethoprim-sulfamethoxazole and cyclines are effective but may induce adverse effects. Nifuroxazide in a dose of 400 mg each day throughout the trip has proved effective. Tolerance was outstanding with no adverse effects.
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use*; D003967:Diarrhea / Q000517:prevention & control*; D004534:Egypt; D006801:Humans; D062385:Hydroxybenzoates / Q000627:therapeutic use*; D008800:Mexico; D008875:Middle Aged; D009581:Nitrofurans / Q000627:therapeutic use*; D014195:Travel
D000890:Anti-Infective Agents; D000930:Antidiarrheals; D062385:Hydroxybenzoates; D009581:Nitrofurans; C013150:nifuroxazide
Essai de chimioprophylaxie de la diarrhée du voyageur par le nifuroxazide.